The genetic inhibition of CaMKII oxidation reduced the propensity for AF, suggesting that CaMKII acts as a coupler between oxidative stress and atrial arrhythmia (Purohit et al., 2013). The gene discussed is CAMK2G; the disease is atrial fibrillation.